← Leaderboards
Brian Tshao Do
Massachusetts Institute Of Technology
$155,482
Attributed
$155,482
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $52.7K · FY2021–23$100K$75K$50K$25K$0
'21
'22
'23
Funding mix
By agency
NIH$155,482 · 1
By mechanism
F30$155,482 · 1
Top collaborators
No co-investigators on record.
Most similar at Massachusetts Institute Of Technology
Same institution · by research overlap
- Joanne Stubbe$16,578,287
- Catherine L Drennan$8,076,261
- Jane-Jane Chen$5,525,108
- Thomas J Begley$14,062,480
- Marina L Bennati$103,795
Others in their field
Other Emerging Leaders on “Fetal Hemoglobin”
- Camille Elise Powe · Massachusetts General Hospital$6,615,203
- Lionel Blanc · Feinstein Institute For Medical Research$5,499,553
- Jane Caroline Khoury · Cincinnati Childrens Hosp Med Ctr$2,637,022
- Ying He · University Of Illinois At Chicago$2,536,105
- David Richard Light · Illexcor Therapeutics, Llc$2,393,906
- Shabnam Peyvandi · University Of California, San Francisco$2,188,348
Research focus
Fetal HemoglobinFoundationsBar CodesAdultBeta GlobinFetusBostonCandidate Disease GeneCareer DevelopmentAffectCellsCharacteristicsBone MarrowAmericanDesignDevelopment PlansDisease ManagementErythrocytesErythroidErythroid CellsErythroid DifferentiationErythropoiesisExperimental StudyGamma Globin
Grant awards (4)
Molecular determinants of fetal hemoglobin induction by hydroxyurea to treat sickle cell disease$30,498
F30 · FY2023 · HL · contact PI
Molecular determinants of fetal hemoglobin induction by hydroxyurea to treat sickle cell disease$22,196
F30 · FY2023 · HL · contact PI
Molecular determinants of fetal hemoglobin induction by hydroxyurea to treat sickle cell disease$51,752
F30 · FY2022 · HL · contact PI
Molecular determinants of fetal hemoglobin induction by hydroxyurea to treat sickle cell disease$51,036
F30 · FY2021 · HL · contact PI